CHEARS

COVID19 Update : FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests

New Therapy Approved for TIO

AOSD patients Got Their First Treatment

Drug Approved to Treat Infants and Children with HIV

New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord

Subcutaneous Formulation of Daratumumab Approved

e-Newsletter : April 2020

Hydroxychloroquine or Chloroquine for COVID-19 – FDA Cautions for Risk of Heart Rhythm Problem

Opicapone – approved for the Parkinson’s Patient Experiencing “Off” Episodes